GC-5131

N/A

Report date: 2026/04/23 20:00:25

Base Information

Drug NameGC-5131
Drug Alias NameGC-5131GC-5131A
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunoglobulin agonists
TargetsImmunoglobulin
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGreen Cross Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGC Biopharma Corp
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A